Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 107Lymphoma 48Lymphoma, Non-Hodgkin 44Hodgkin Disease 44Leukemia, Myeloid, Acute 41Myelodysplastic Syndromes 40Leukemia 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Lymphocytic, Chronic, B-Cell 28Lymphoma, Mantle-Cell 26Neoplasms, Plasma Cell 25Lymphoma, Large B-Cell, Diffuse 24Lymphoma, Follicular 24Lymphoma, B-Cell, Marginal Zone 18Burkitt Lymphoma 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Myeloproliferative Disorders 16Recurrence 14Immunoglobulin Light-chain Amyloidosis 14Congenital Abnormalities 13Primary Myelofibrosis 12Lymphoma, Large-Cell, Immunoblastic 12Leukemia, Myeloid, Accelerated Phase 12Hematologic Neoplasms 12Waldenstrom Macroglobulinemia 10Lymphoma, T-Cell, Cutaneous 10Leukemia, Myelomonocytic, Juvenile 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Chronic-Phase 10Dendritic Cell Sarcoma, Interdigitating 10

Interventions

Exercise 9Resistance Training 6Metformin 3Fitness Trackers 2secukinumab 1YES1 protein, human 1Wearable Electronic Devices 1Vincristine 1Therapeutics 1Thalidomide 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Platelet Transfusion 1Physical Therapy Modalities 1Peripheral Blood Stem Cell Transplantation 1Nutrition Assessment 1Methods 1Melphalan 1Jogging 1High-Intensity Interval Training 1Heparin, Low-Molecular-Weight 1Green Or 1Etoposide 1Erythrocyte Transfusion 1Epoetin Alfa 1Dyrk Kinases 1Doxorubicin 1Diet Therapy 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Motor Activity × Melphalan × Clear all
NCT00577096 2015-04-06

Effects of Exercise in Combination With Epoetin Alfa

University of Arkansas

Phase NA Completed
120 enrolled 16 charts
Plasma cell

Motor Activity, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡